Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204 Life Science Investing
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium 2026 Life Science Investing
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results Life Science Investing
How Conservationists Are Using Healthcare Technology To Protect Vulnerable Species Medical Device Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center Biotech Investing
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application for PRT12396, a Mutant-selective JAK2V617F Inhibitor Life Science Investing
Allergan Aesthetics Continues Its Mission of Empowering Women Through the Faces of Natrelle® Testimonial Program Pharmaceutical Investing
Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology Technology Investing
Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team Life Science Investing
